Haptoglobin deficiency facilitates the development of autoimmune inflammation

European Journal of Immunology

Volumn 39, Issue 12, 2009, Pages 3404-3412

  Galicia, Georgina ^a   Maes, Wim ^a   Verbinnen, Bert ^a   Kasran, Ahmad ^a   Bullens, Dominique ^a   Arredouani, Mohamed ^a,b   Ceuppens, Jan L ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; EAE; Haptoglobin; MOG; Th17 cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HAPTOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNIZATION; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD; TH2 CELL; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HAPTOGLOBINS; IMMUNIZATION; IMMUNOGLOBULIN G; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; SPLEEN; T-LYMPHOCYTES; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 73249125378     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939291     Document Type: Article

References (35)

1. Gabay, C. and Kushner, I., Acute-phase proteins and other systemic responses to inflammation. N Engl. J. Med. 1999. 340: 448-454.
2. Wang, Y., Kinzie, E., Berger, F. G., Lim, S. K. and Baumann, H., Haptoglobin, an inflammation-inducible plasma protein. Redox Rep. 2001. 6: 379-385.
3. D'Armiento, J., Dalal, S. S. and Chada, K., Tissue, temporal and inducible expression pattern of haptoglobin in mice. Gene 1997. 195: 19-27.
4. Quaye, I. K., Haptoglobin, inflammation and disease. Trans. R. Soc. Trop. Med. Hyg. 2008. 102: 735-742.
5. Oliviero, S. and Cortese, R., The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. EMBO J. 1989. 8: 1145-1151.
6. Lim, S. K., Kim, H., Lim, S. K., bin Ali, A., Lim, Y. K., Wang, Y., Chong, S. M. et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998. 92: 1870-1877.
7. Rossbacher, J., Wagner, L. and Pasternack, M. S., Inhibitory effect of haptoglobin on granulocyte chemotaxis, phagocytosis and bactericidal activity. Scand. J. Immunol. 1999. 50: 399-404.
8. Arredouani, M. S., Kasran, A., Vanoirbeek, J. A., Berger, F. G., Baumann, H. and Ceuppens, J. L., Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005. 114: 263-271.
9. El-Ghmati, S. M., Van Hoeyveld, E. M., Van Strijp, J. G., Ceuppens, J. L. and Stevens, E. A., Identification of haptoglobin as an alternative ligand for CD11b/CD18. J .Immunol. 1996. 156: 2542-2552.
10. Nielsen, M. J., Moestrup, S. K., Receptor-targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009. 114: 764-771.
11. Xie, Y., Li, Y., Zhang, Q., Stiller, M. J., Wang, C. L. and Streilein, J. W., Haptoglobin is a natural regulator of Langerhans cell function in the skin. J. Dermatol. Sci. 2000. 24: 25-37.
12. Huntoon, K. M., Wang, Y., Eppolito, C. A., Barbour, K. W., Berger, F. G., Shrikant, P. A. and Baumann, H., The acute phase protein haptoglobin regulates host immunity. J. Leukoc. Biol. 2008. 84: 170-181.
13. Sospedra, M. and Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683-747.
14. Gold, R., Linington, C. and Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006. 129: 1953-1971.
15. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
16. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535-1541.
17. Dardalhon, V., Korn, T., Kuchroo, V. K. and Anderson, A. C., Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008. 31: 252-256.
18. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D. and Rott, O., Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994. 153: 4258-4267.
19. Bettelli, E., Das, M. P., Howard, E. D., Weiner, H. L., Sobel, R. A. and Kuchroo, V. K., IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998. 161: 3299-3306.
20. Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A. and Coffman, R. L., Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 2001. 166: 602-608.
21. Butti, E., Bergami, A., Recchia, A., Brambilla, E., Del Carro, U., Amadio, S., Cattalini, A. et al. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther. 2008. 15: 504-515.
22. Theilgaard-Monch, K., Jacobsen, L. C., Nielsen, M. J., Rasmussen, T., Udby, L., Gharib, M., Arkwright, P. D. et al. Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood 2006. 108: 353-361.
23. Lee, M. Y., Kim, S. Y., Choi, J. S., Lee, I. H., Choi, Y. S., Jin, J. Y., Park, S. J. et al. Upregulation of haptoglobin in reactive astrocytes after transient forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 2002. 22: 1176-1180.
24. Uyttenhove, C. and Van Snick, J., Development of an anti-IL-17A autovaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 2006. 36: 2868-2874.
25. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
26. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 2007. 13: 423-431.
27. Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 18460-18465.
28. Gu, Y., Yang, J., Ouyang, X., Liu, W., Li, H., Yang, J., Bromberg, J. et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 2008. 38: 1807-1813.
29. Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H. and Raine, C. S., Myelin antigen -specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001. 166: 7579-7587.
30. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlen, C. and Goverman, J., A pathogenic role for myelin-specific C8+ T cells in a model of multiple sclerosis. J. Exp. Med. 2001. 194: 669-676.
31. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M. et al. Clonal expansion of C8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192: 393-404.
32. Behrens, E. M., Sriram, U., Shivers, D. K., Gallucci, M., Ma, Z., Finkel, T. H. and Gallucci, S., Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J. Immunol. 2007. 178: 6268-6279.
33. Bullard, D. C., Hu, X., Schoeb, T. R., Axtell, R. C., Raman, C. and Barnum, S. R., Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 2005. 175: 6327-6333.
34. Gordon, E. J., Myers, K. J., Dougherty, J. P., Rosen, H. and Ron, Y., Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1995. 62: 153-160.
35. Dubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den, O. J., Sciot, R. et al. Resistance of young gelatinase B-deficientmice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 1999. 104: 1507-1515.